Assessing the Safety and Bioactivity of SG1002 in Heart Failure Patients
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Sulfagenix Australia Pty Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT02278276
Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Other: SG1002Other: Placebo
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Sulfagenix Australia Pty Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01989208
- Locations
- 🇦🇺
Alfred Health, Melbourne, Victoria, Australia
🇦🇺Nucleus Network, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath